Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy.

Li C, Zhang X, Huang X, Wang X, Liao G, Chen Z.

Int J Nanomedicine. 2013;8:1285-92. doi: 10.2147/IJN.S41695. Epub 2013 Mar 24.

2.

[Preparation and transdermal diffusion of flexible nanoliposomes of ginkgolide B].

Liu T, Zhen X, Cheng H, Li W, Hao B.

Zhongguo Zhong Yao Za Zhi. 2009 Sep;34(17):2181-4. Chinese.

PMID:
19943480
3.

Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.

Ferreira IS, Bettencourt AF, Gonçalves LM, Kasper S, Bétrisey B, Kikhney J, Moter A, Trampuz A, Almeida AJ.

Int J Nanomedicine. 2015 Jul 7;10:4351-66. doi: 10.2147/IJN.S84108. eCollection 2015.

4.

Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment.

Lin CH, Fang YP, Al-Suwayeh SA, Yang SY, Fang JY.

Biol Pharm Bull. 2013;36(2):276-86.

5.

Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.

Ferreira IS, Bettencourt A, Bétrisey B, Gonçalves LM, Trampuz A, Almeida AJ.

Int J Pharm. 2015 May 15;485(1-2):171-82. doi: 10.1016/j.ijpharm.2015.03.016. Epub 2015 Mar 12.

PMID:
25772414
6.

Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes.

Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, Götz F, Manosroi W, Manosroi J.

Int J Pharm. 2010 Jun 15;392(1-2):304-10. doi: 10.1016/j.ijpharm.2010.03.064. Epub 2010 Apr 8.

PMID:
20381599
7.

Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis.

Silva NC, Silva S, Sarmento B, Pintado M.

Drug Deliv. 2015;22(7):885-93. doi: 10.3109/10717544.2013.858195. Epub 2013 Nov 25.

PMID:
24266551
8.

Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.

Parra-Ruiz J, Vidaillac C, Rose WE, Rybak MJ.

Antimicrob Agents Chemother. 2010 Oct;54(10):4329-34. doi: 10.1128/AAC.00455-10. Epub 2010 Aug 9.

9.

A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.

Bauer J, Siala W, Tulkens PM, Van Bambeke F.

Antimicrob Agents Chemother. 2013 Jun;57(6):2726-37. doi: 10.1128/AAC.00181-13. Epub 2013 Apr 9.

10.

Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.

Lefèvre S, Saleh M, Marcellin L, Subilia A, Bourcier T, Prévost G, Jehl F.

Antimicrob Agents Chemother. 2012 May;56(5):2485-92. doi: 10.1128/AAC.05745-11. Epub 2012 Feb 27.

11.

Development and characterization of a novel antiacne niosomal gel of rosmarinic acid.

Budhiraja A, Dhingra G.

Drug Deliv. 2015;22(6):723-30. doi: 10.3109/10717544.2014.903010. Epub 2014 Apr 30.

PMID:
24786487
12.

Liposomal hydrogel formulation for transdermal delivery of pirfenidone.

Jose A, Mandapalli PK, Venuganti VV.

J Liposome Res. 2016;26(2):139-47. doi: 10.3109/08982104.2015.1060611. Epub 2015 Jun 26.

PMID:
26114208
13.

Physicochemical characterization and skin permeation of liposome formulations containing clindamycin phosphate.

Shanmugam S, Song CK, Nagayya-Sriraman S, Baskaran R, Yong CS, Choi HG, Kim DD, Woo JS, Yoo BK.

Arch Pharm Res. 2009 Jul;32(7):1067-75. doi: 10.1007/s12272-009-1713-0. Epub 2009 Jul 31.

PMID:
19641889
14.

Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus.

El Haj C, Murillo O, Ribera A, Vivas M, Garcia-Somoza D, Tubau F, Cabellos C, Cabo J, Ariza J.

Int J Antimicrob Agents. 2015 Aug;46(2):189-95. doi: 10.1016/j.ijantimicag.2015.04.004. Epub 2015 May 21.

PMID:
26051988
15.

Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages.

Pati R, Mehta RK, Mohanty S, Padhi A, Sengupta M, Vaseeharan B, Goswami C, Sonawane A.

Nanomedicine. 2014 Aug;10(6):1195-208. doi: 10.1016/j.nano.2014.02.012. Epub 2014 Mar 6.

PMID:
24607937
16.

Intradermal and follicular delivery of adapalene liposomes.

Kumar V, Banga AK.

Drug Dev Ind Pharm. 2016;42(6):871-9. doi: 10.3109/03639045.2015.1082580. Epub 2015 Sep 7.

PMID:
27031916
17.

Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.

Chen Y, Zhou L, Yuan L, Zhang ZH, Liu X, Wu Q.

Int J Nanomedicine. 2012;7:3023-32. doi: 10.2147/IJN.S32476. Epub 2012 Jun 19.

18.

Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.

Siala W, Mingeot-Leclercq MP, Tulkens PM, Hallin M, Denis O, Van Bambeke F.

Antimicrob Agents Chemother. 2014 Nov;58(11):6385-97. doi: 10.1128/AAC.03482-14. Epub 2014 Aug 11.

19.

Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.

Louie A, Kaw P, Liu W, Jumbe N, Miller MH, Drusano GL.

Antimicrob Agents Chemother. 2001 Mar;45(3):845-51.

20.

Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.

Meije Y, Almirante B, Del Pozo JL, Martín MT, Fernández-Hidalgo N, Shan A, Basas J, Pahissa A, Gavaldà J.

J Infect. 2014 Jun;68(6):548-52. doi: 10.1016/j.jinf.2014.01.001. Epub 2014 Jan 8.

PMID:
24412247

Supplemental Content

Support Center